ARTICLE SUMMARY:
Recor Medical, an Otsuka subsidiary, is expanding access to its Paradise ultrasound renal denervation technology with the help of national Medicare coverage, professional guidelines, and clinical results supporting renal denervation for the treatment of drug-resistant hypertension.
Three years after it launched the Paradise ultrasound renal denervation (RDN) system in the US, Recor Medical is addressing the remaining barriers keeping patients with uncontrolled hypertension from accessing this potentially life-changing therapy.
